Evolutionary routes and KRAS dosage define pancreatic cancer phenotypesSebastian Mueller, Roland Rad, Hsi-Yu Yen et al.|Nature|2018Cited by 455
A new patient‐derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of α‐dystroglycanJihee Kim, Yung‐Yao Lin, Beatrice Lana et al.|EMBO Reports|2019Cited by 23
Optogenetic modeling of human neuromuscular circuits in Duchenne muscular dystrophy with CRISPR and pharmacological correctionsAmaia Paredes‐Redondo, Yung‐Yao Lin, Peter Harley et al.|Science Advances|2021Cited by 19
Targeted gene correction of <i>FKRP</i> by CRISPR/Cas9 restores functional glycosylation of α-dystroglycan in cortical neurons derived from human induced pluripotent stem cellsBeatrice Lana, Yung‐Yao Lin, Jihee Kim et al.|bioRxiv (Cold Spring Harbor Laboratory)|2017Cited by 0
Abstract 391: Evolutionary trajectories and <i>KRAS</i> gene dosage define pancreatic cancer phenotypesSebastian Mueller, Roland Rad, Thomas Engleitner et al.|Cancer Research|2018Cited by 0